---
document_datetime: 2025-02-18 16:42:25
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/balversa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: balversa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.0188464
conversion_datetime: 2025-12-30 00:16:27.491599
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Balversa

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,pleasealsorefertoEPAR-Procedural stepstakenandscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued2/ amended on   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|-------------------------------------------|---------------------------------|-----------|
| Variation type IA / | This was an application for a group of | 18/03/2025                          | N/A                                       | SmPC,                           |           |

SendusaquestionGotowww.ema.europa.eu/contactTelephone+31(0)887816000

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000248998   | variations. B.1.b.2 Change in test procedure for active substanceorstarting material/reagent/intermediate used in the manufacturing process of the active substance-B.I.b.2.a Minor changes to an approved test procedure-Accepted B.I1.b.5Changetoin-processtestsorlimits applied during the manufacture of the finishedproduct-B.II.b.5.zMinor change of ananalyticalprocedurefor anin-process control - Accepted B.II.e.1.b Change in type of container or addition of a new container-B.lI.e.1.b.3 Deletion of an immediate packaging containerthatdoesnotleadtothecomplete deletionofastrengthorpharmaceutical form - Accepted   | Labelling and PL   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|